Navigation Links
Kessler Foundation's James Sumowski, Ph.D., speaks at April 18-19 MS Symposium in Toronto
Date:4/17/2013

West Orange, NJ. April 17, 2013. James Sumowski, PhD, of Kessler Foundation is among the invited MS experts presenting at the 2013 University of Toronto Neuro-inflammation Symposium and endMS RRTC Retreat on Thursday, April 18, 2013 - Friday, April 19, 2013, 8:30 AM - 1:00 PM at the Chestnut Residence and Conference Centre in Toronto. Dr. Sumowski is a research scientist in Neuropsychology & Neuroscience Research, under the directorship of Nancy Chiaravalloti, PhD. Drs. Sumowski and Chiaravalloti are on the faculty of the department of physical medicine and rehabilitation at UMDNJ-New Jersey Medical School.

Dr. Sumowski's presentation on April 19 will address 'Brain reserve and cognitive reserve in multiple sclerosis: Independent and differential contributions of maximal lifetime brain growth and cognitively active lifestyles to cognitive status.'


'/>"/>

Contact: Carolann Murphy, PA
CMurphy@KesslerFoundation.org
973-324-8382
Kessler Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. Dr. DeLuca of Kessler Foundation speaks at Consortium of MS Centers meeting in Chicago
2. Kessler Foundation scientists receive Consortium of MS Centers grant to study emotional processing
3. Kessler Foundation scientist receives National MS Society grant for predictors of memory decline
4. Kessler Foundation scientist receives National MS Society grant for new memory study
5. Kessler Foundation researchers share findings in rehabilitation research at AAN meeting in San Diego
6. Kessler Foundation named site for major study of wheelchair use in spinal cord injury
7. John DeLuca, Ph.D., of Kessler Foundation delivers keynote at IPMSC meeting in Milan
8. Push to Walk Receives Grant from the Kessler Foundation
9. Kessler awarded $2 million federal grant for Northern NJ Traumatic Brain Injury System
10. Happtique and Kessler Foundation lead new working group of application developers alliance
11. Kessler Foundation wins National MS Society grant to study prevention of cognitive decline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... New York (PRWEB) , ... May 23, 2017 ... ... NextGen LifeLabs, a leading equipment provider in the modern ART laboratory, to provide ... Institute in Ft. Lauderdale, Florida. , NextGen LifeLabs, a MedTech Group Purchasing ...
(Date:5/23/2017)... MA (PRWEB) , ... May 23, 2017 , ... Orbita’s ... on Tuesday, May 23, 2017 in San Francisco. Titled Connected Health and IoT: ... Connected Home Event hosted by Parks Associates, a market research and consulting firm ...
(Date:5/23/2017)... San Francisco, California (PRWEB) , ... May 23, 2017 , ... ... released results of its new survey in an infographic on the current state of ... 900 U.S. respondents, familiar with anxiety, was conducted in April 2017 and benchmarked general ...
(Date:5/22/2017)... Kisco, NY (PRWEB) , ... May 22, 2017 , ... ... are urged to receive relaxing sedation dentistry in Mt. Kisco, NY from Advanced Endodontics ... be administered for a variety of treatments. One or more sedation methods may be ...
(Date:5/22/2017)... ... May 22, 2017 , ... An inventor from Columbia, S.C., ... pen. "My wife’s hand was damaged in a firework accident, so she couldn’t grip ... with manual problems." , He then designed and created a prototype for the HELPEN ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)...  The Corporate Whistleblower Center says, "We are ... clinics to call us anytime at 866-714-6466 if they ... in a substantial scheme to overbill Medicare. We ... employee of a medical equipment company if their ... medical practice groups with extra generous incentives to use, ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
Breaking Medicine Technology: